Get the Stockscreener App
54.76
3.86%
-2.20
Proshares Ultra Nasdaq Biotechnology 2 X Shares stock is traded at $54.76, with a volume of 6,488.
It is down -3.86% in the last 24 hours and up +3.89% over the past month.
See More
Previous Close:
$56.96
Open:
$56.42
24h Volume:
6,488
Relative Volume:
0.57
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.56%
1M Performance:
+3.89%
6M Performance:
-6.46%
1Y Performance:
-2.46%
1-Day Range:
$54.76
$56.46
1-Week Range:
$53.52
$58.94
52-Week Range:
$47.20
$69.56
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Company Profile
Name
Proshares Ultra Nasdaq Biotechnology 2 X Shares
Sector
Industry
Phone
-
Address
-
Compare BIB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIB
Proshares Ultra Nasdaq Biotechnology 2 X Shares
|
54.84 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
298.12 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
600.94 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
603.81 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
247.71 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
523.39 | 124.43B | 0 | 0 | 0 | 0.00 |
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Latest News
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Pass Above 50-Day Moving AverageWhat's Next? - MarketBeat
Best Stocks Under $50 Right Now - Benzinga
Stock Market Movers Today • Top Gainers & Losers - Benzinga
UltraShort Bitcoin ETF Offering 2x Inverse Returns Sees Record Volume as BTC Holds Above $90K - Yahoo Finance
ProShares S&P Technology Dividend Aristocrats ETF (BATS:TDV) Stock Pass Above Two Hundred Day Moving Average – Here’s Why - Defense World
Top Performing Leveraged/Inverse ETFs: 11/17/2024 - ETF Trends
UGL 2x Gold 15% Dump: Start To Be A Potentially Risky Choice (NYSEARCA:UGL) - Seeking Alpha
Top Tech ETFs Right Now - Benzinga
Best Inverse ETFs Of 2024 - Forbes
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update - MarketBeat
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
Squarepoint Ops LLC Purchases Shares of 22,043 ProShares Ultra Russell2000 (NYSEARCA:UWM) - Defense World
Inverse ETFs: Definition and Best-Performing Examples for October 2024 - NerdWallet
5 Best Leveraged ETFs of the First Nine Months of 2024 - Yahoo Finance
Best ETFs for Day Trading – Updated Lists and Statistics - TradeThatSwing
Semiconductor ETFs Take A Beating, Dragged Lower By Nvidia, AMD, and Broadcom Stocks - Yahoo Finance
Nvidia ETFs Split In Pre-Market After Jensen Huang-Led Chip Giant Exceeds Q2 Expectations - Benzinga
ProShares Ultra Bloomberg Natural Gas (NYSEARCA:BOIL) Stock Cross Below 50-Day Moving Average of $11.94 - Defense World
Galapagos (NASDAQ:GLPG) Shares Gap Up to $24.89 - Defense World
Best Stocks Under $20 Right Now - Benzinga
Best 2x Leveraged ETFs - Benzinga
UVXY: The VIX Is Too Low (BATS:UVXY) - Seeking Alpha
BITU May Be Too Risky At 2x Leverage - Seeking Alpha
5 Best-Performing Leveraged ETFs of 1H - Yahoo Finance
5 Best-Performing Leveraged ETFs of May - Yahoo Finance
Top Performing Leveraged/Inverse ETFs: 05/19/2024 - Nasdaq
Top Performing Leveraged/Inverse ETFs: 05/12/2024 - Nasdaq
How To Trade Biotech Stocks: Can These Three Tips Help You Make More Profits? - Investor's Business Daily
The 5 Best Healthcare ETFs of 2023 - etf.com
Top Performing Leveraged/Inverse ETFs: 04/07/2024 - Nasdaq
ProShares Debuts 2X Leveraged/Inverse Bitcoin ETFs - Nasdaq
5 Best Leveraged ETFs of the First Quarter of 2024 - Yahoo Finance
Leveraged ETFs to Ride on S&P's New 5,200 Milestone - Yahoo Finance
A Guide to the 10 Most Popular Leveraged ETFs - Yahoo Finance
Top Performing Leveraged/Inverse ETFs: 03/03/2024 - ETF Trends
5 Best-Performing Leveraged ETFs of February - Yahoo Finance
Nvidia Sparks Double-Digit Rally in These Leveraged ETFs - Nasdaq
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 - InvestorPlace
5 Leveraged ETFs Winning on the Tech Sector Rally - Yahoo Finance
10 Best Performing Healthcare ETFs in 2023 - Yahoo Finance
Oil Jumps on Middle East Conflict, Leveraged ETFs to Profit - Yahoo Finance
Dig Oil With These Leveraged Energy ETFs - Yahoo Finance
QLD: Volatility Can Hurt This More Than Direction (NYSEARCA:QLD) - Seeking Alpha
How to Capture the Benefits of Dividend Increases - MarketBeat
10 Inverse ETFs That Gain in a Bear Market - U.S News & World Report Money
Most popular ETFs for Aussie investors revealed - Yahoo Finance Australia
Top Performing Leveraged/Inverse ETFs: 05/14/2023 - Nasdaq
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering & Biotechnology News
ProShares aims to launch a 2X leveraged Bitcoin Strategy ETF - Seeking Alpha
Top Performing Leveraged/Inverse ETFs: 04/02/2023 - Nasdaq
Top Performing Leveraged/Inverse ETFs: 03/12/2023 - Nasdaq
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Financials Data
There is no financial data for Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):